GMAB

SEC filing GMAB Director Michael Kavanagh Sells 526 Shares at DKK 1,734.75 on NASDAQ Copenhagen

3d ago

News Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

14d ago

News Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough

14d ago

News Down -14.68% in 4 Weeks, Here's Why Genmab Looks Ripe for a Turnaround

14d ago

News AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock? - Zacks Investment Research

14d ago

News ISS suggest Enhabit shareholders elect three AREX Capital nominees to board By Reuters - Investing.com

14d ago

News FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

14d ago

News AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway

14d ago

News What 9 Analyst Ratings Have To Say About Genmab

14d ago

SEC filing GMAB Raises $3.0M from Employee Warrant Exercise, Increases Share Capital by 2,346 Shares

20d ago

SEC filing GMAB Reports $896M Revenue, $181M YoY Growth, FDA Approves sBLA, $742M Royalties, $237M Op Profit Ex Items

25d ago

News Genmab Q1 2026 Earnings Preview

26d ago

SEC filing GMAB Share Capital Reduction: Nominal Value Cut by DKK 1.9M, 1.9M Shares Cancelled, New Capital DKK 62.35M, 62.35M Shares Remain, Effective April 21, 2026

45d ago

SEC filing GMAB Major Shareholder: Orbis Investment Management Holds 3.11M Shares (4.85%)

48d ago

SEC filing GMAB Reports $3.96B DARZALEX Net Sales, $2.21B U.S. Sales, $1.76B Global Royalties

49d ago

News Genmab confirms $3.96B DARZALEX sales in Q1, led by U.S. demand

49d ago

SEC filing GMAB Reports $1.2B Revenue, $0.45 EPS, +18% YoY Growth

71d ago

SEC filing GMAB Board Constitutes Chair Connelly Deputy Chair Erenbjerg Grants 5,213 RSUs 4,485 Warrants Fair Value DKK 1,645 RSU Value DKK 530.62 Warrant Exercise Price DKK 1,645 Vesting 3 Years Expiry 7 Years

74d ago

SEC filing GMAB AGM Approves 2025 Profit Carryforward, Reelects Board, Deloitte Auditor, Capital Reduction Plan

75d ago

SEC filing GMAB Completes $725M Buyback, Repurchases 93,130 Shares at Avg 1,717 DKK, Holds 4.45% Treasury

78d ago

SEC filing GMAB Reports $1.2B Revenue, $0.45 EPS, +18% YoY Growth

89d ago

SEC filing GMAB Buys Back 85K Shares for DKK 157M Under DKK 725M Program

91d ago

SEC filing GMAB Repurchases 63,000 Shares for $115M, Holds 2,678,851 Treasury Shares Worth 4.17% of Total Share Capital

98d ago

SEC filing GMAB Announces Annual General Meeting March 19 2026 at Copenhagen Marriott Hotel with USD 963M Profit Carryforward and Board Election Proposals

103d ago

News Genmab GAAP EPS of $15.37, revenue of $3.72B misses by $50M; initiates FY26 outlook

104d ago